Cytek Biosciences Inc Receivables Turnover Ratio (CTKB), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Cytek Biosciences Inc   (NASDAQ: CTKB)
 

Cytek Biosciences Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Cytek Biosciences Inc 's ability to collect accounts receivable sequentially worsen to 3.7, pointing to a challenging and on top of that deteriorating business climate for the Laboratory Analytical Instruments industry. Cytek Biosciences Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 99 days, from 98 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 449 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 2224 to 2942.

What is Receivable Turnover Ratio?
What is Cytek Biosciences Inc Selling?


What is Receivable Turnover Ratio?





CTKB Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change 4.52 % -11.62 % -5.68 % 3.17 % 7.6 %
Y / Y Revenue Change 3.26 % 5.57 % 5.1 % 5.95 % 1.07 %
Receivable Turnover Ratio (TTM) 3.7 3.72 3.56 3.48 3.45
CTKB's Total Ranking # 2942 # 2224 # 2705 # 1926 #
Accounts Receivable average collection period days 99 98 102 105 106
Seq. Receivable Change 19.1 % -4.25 % -16.97 % 10.38 % 0.71 %
Seq. Revenue Change 10.57 % 11.3 % -30.39 % 20.54 % 13.05 %


Receivable Turnover Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 21
Healthcare Sector # 450
Overall Market # 2942

Receivable Turnover Ratio Statistics
High Average Low
6.15 4.08 3.45
(Dec 31 2021)   (Sep 30 2025)






Financial Statements
Cytek Biosciences Inc 's Accounts Receivable $ 59 Millions Visit CTKB's Balance sheet
Cytek Biosciences Inc 's Sales TTM $ 207 Millions Visit CTKB's Income Statement
Sources of CTKB's Revenues Visit CTKB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Laboratory Analytical Instruments Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CTKB's Receivable Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CTKB's Growth Rates CTKB's Roa CTKB's Inventory Turnover Ratio CTKB's Dividend Comparisons
CTKB's Profitability Ratios CTKB's Roi CTKB's Asset Turnover Ratio CTKB's Dividend Growth
CTKB's Valuation Ratios CTKB's Roe CTKB's Financial Strength Ratios CTKB's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Adapthealth Corp   8.14 $ 3,152.043  Millions$ 387.280  Millions
Rhythm Pharmaceuticals Inc   8.03 $ 280.748  Millions$ 34.950  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Henry Schein Inc   7.84 $ 13,734.000  Millions$ 1,752.000  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Madrigal Pharmaceuticals Inc   7.70 $ 1,427.940  Millions$ 185.380  Millions
Pulmonx Corporation  7.56 $ 89.176  Millions$ 11.791  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions
Novocure Limited  7.44 $ 725.388  Millions$ 97.525  Millions
Intuitive Surgical Inc   7.44 $ 12,115.600  Millions$ 1,629.350  Millions
Quest Diagnostics Inc  7.43 $ 11,841.000  Millions$ 1,593.250  Millions
Travere Therapeutics Inc   7.32 $ 651.034  Millions$ 88.900  Millions
Si bone inc   7.19 $ 222.189  Millions$ 30.881  Millions
Aurinia Pharmaceuticals Inc   7.18 $ 321.738  Millions$ 44.795  Millions
Beta Bionics Inc   7.15 $ 127.899  Millions$ 17.897  Millions

Date modified: 2026-11-06T13:05:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.